Decisional early interim (18)F-fluoro-2-deoxy-D-glucose positron emission tomography after two cycles of chemotherapy in de novo Hodgkin lymphoma.

Iltis, Aurore; Eder, Veronique; Blasco, Helene; Colombat, Philippe; Sénécal, Delphine

Iltis, Aurore; Eder, Veronique; Blasco, Helene; Colombat, Philippe; Sénécal, Delphine.

Affiliation

Iltis A; Department of Hematology and Cellular Therapy, Bretonneau University Hospital, Tours, France.

Acta Haematol ; 133(2): 172-8, 2015.

Article in En | MEDLINE | ID: mdl-25301496

Subject(s)

Fluorodeoxyglucose F18/administration & dosage; Hodgkin Disease/diagnostic imaging; Hodgkin Disease/drug therapy; Hodgkin Disease/mortality; Positron-Emission Tomography; Radiopharmaceuticals/administration & dosage; Adolescent; Adult; Aged; Decision Making; Disease-Free Survival; Female; Humans; Male; Middle Aged; Radiography; Retrospective Studies; Survival Rate

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hodgkin Disease / Radiopharmaceuticals / Fluorodeoxyglucose F18 / Positron-Emission Tomography Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Acta Haematol Year: 2015 Document type: Article Affiliation country: France Country of publication: Switzerland

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google